SEC Form 4 · accession 0001209191-15-065922
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey William Henderson
Director
Period of report
Aug 6, 2015
Accepted (ET)
Aug 13, 2015 · 7:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $22.09 | Aug 6, 2015 | A | 12,000 | A | — | Aug 6, 2025 | Common Stock | 12,000 | 12,000 | D |
| Stock Option (Right to Buy)F2,F3 | $22.09 | Aug 6, 2015 | A | 9,896 | A | — | Aug 6, 2025 | Common Stock | 9,896 | 9,896 | D |
Explanation of responses
- F1Option vests quarterly over three years from August 6, 2015.
- F2Not applicable.
- F3Option vests as to 896 shares on 9/3/2015, 3,000 shares on 12/3/15, 3,000 shares on 3/3/16 and 3,000 shares on 6/3/16.